Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)
Clinical trial NCT04319159 · COMPLETED
Trial details
- NCT number
- NCT04319159
- Sponsor
- Biofrontera Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-05
- Primary completion
- 2020-09-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.